Objective: The purpose of this study was to examine the magnitude of the re
lation between a postmenopausal woman's hormonal replacement status and cli
nical pain report in a sample of women experiencing orofacial pain.
Design: To accomplish this, pain ratings were collected during a routine ch
ronic pain evaluation at an orofacial pain clinic from a sample of 87 postm
enopausal women.
Results: Results of ANCOVA (controlling for pain duration) demonstrated tha
t postmenopausal women receiving hormone replacement therapy (HRT) reported
higher levels of pain than postmenopausal women not taking HRT. Numeric pa
in rating scales revealed large effect sizes for worst pain report (0.62),
moderate differences for average (0.48) and current (0.39) pain levels, and
trivial differences for least pain (0.04). Effect sizes for the McGill Pai
n Questionnaire indicated somewhat smaller differences (0.35-0.24) between
the two groups.
Conclusions: This study is among the first to examine the relation between
a woman's hormonal status and clinical pain perception and is the first to
investigate the role of HRT in a postmenopausal woman's orofacial pain repo
rt in a clinical treatment setting. This area of inquiry is particularly sa
lient given the high percentage of women who choose to initiate HRT either
after hysterectomy or with the onset of menopause.